日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON

在进行性肺纤维化患者中继续使用尼达尼布治疗:来自 INBUILD-ON 研究的数据

Wuyts, Wim A; Bonella, Francesco; Chaudhuri, Nazia; Varone, Francesco; Antin-Ozerkis, Danielle; Song, Jin Woo; Miede, Corinna; Dumistracel, Mihaela; Coeck, Carl; Cottin, Vincent

Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease

达比加群用于治疗和二级预防儿童先天性心脏病静脉血栓栓塞

Albisetti, Manuela; Tartakovsky, Igor; Halton, Jacqueline; Bomgaars, Lisa; Chalmers, Elizabeth; Mitchell, Lesley G; Luciani, Matteo; Nurmeev, Ildar; Gorbatikov, Kirill; Miede, Corinna; Brueckmann, Martina; Brandão, Leonardo R

Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial

体重减轻与进行性肺纤维化患者的预后:来自 INBUILD 试验的数据

Kreuter, Michael; Bendstrup, Elisabeth; Jouneau, Stéphane; Maher, Toby M; Inoue, Yoshikazu; Miede, Corinna; Lievens, Dirk; Crestani, Bruno

Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial

在随机、安慰剂对照的SENSCIS试验中,接受尼达尼布治疗的系统性硬化症相关间质性肺病患者发生营养不良的风险

Volkmann, Elizabeth R; McMahan, Zsuzsanna H; Smith, Vanessa; Jouneau, Stéphane; Miede, Corinna; Alves, Margarida; Herrick, Ariane L

Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score

尼达尼布治疗系统性硬化症相关间质性肺病患者:按自身抗体状态和改良罗德南皮肤厚度评分进行亚组分析

Kuwana, Masataka; Allanore, Yannick; Denton, Christopher P; Distler, Jörg H W; Steen, Virginia; Khanna, Dinesh; Matucci-Cerinic, Marco; Mayes, Maureen D; Volkmann, Elizabeth R; Miede, Corinna; Gahlemann, Martina; Quaresma, Manuel; Alves, Margarida; Distler, Oliver

Educational Automatic Question Generation Improves Reading Comprehension in Non-native Speakers: A Learner-Centric Case Study

教育领域自动问题生成技术提升非母语人士阅读理解能力:以学习者为中心的案例研究

Steuer, Tim; Filighera, Anna; Tregel, Thomas; Miede, André

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

肺功能下降对系统性硬化症相关间质性肺病(SSc-ILD)患者住院事件发生时间的影响:联合模型分析

Kreuter, Michael; Del Galdo, Francesco; Miede, Corinna; Khanna, Dinesh; Wuyts, Wim A; Hummers, Laura K; Alves, Margarida; Schoof, Nils; Stock, Christian; Allanore, Yannick

Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial

SENSCIS试验中系统性硬化症相关间质性肺病患者的呼吸困难和咳嗽

Volkmann, Elizabeth R; Kreuter, Michael; Hoffmann-Vold, Anna M; Wijsenbeek, Marlies; Smith, Vanessa; Khanna, Dinesh; Denton, Christopher P; Wuyts, Wim A; Miede, Corinna; Alves, Margarida; Sambevski, Steven; Allanore, Yannick

Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial

对接受经皮冠状动脉介入治疗(PCI)治疗ST段抬高型心肌梗死后合并房颤的患者进行达比加群双重抗血栓治疗:一项随机RE-DUAL PCI试验的事后分析

Zeymer, Uwe; Leiva, Orly; Hohnloser, Stefan H; Steg, Philippe Gabriel; Oldgren, Jonas; Nickenig, Georg; Gabor Kiss, Robert; Ongen, Zeki; Navarro Estrada, Jose; Oude Ophuis, Ton; Lip, Gregory Y H; Nordaby, Matias; Miede, Corinna; Ten Berg, Jurrien M; Bhatt, Deepak L; Cannon, Christopher P

The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)

性别对房颤患者经皮冠状动脉介入治疗后达比加群双重抗血栓治疗与华法林三重抗血栓治疗的疗效和安全性的影响(RE-DUAL PCI 亚组分析及与其他双重抗血栓治疗试验的比较)

Eccleston, David S; Kim, Joseph M; Ten Berg, Jurien M; Steg, P Gabriel; Bhatt, Deepak L; Hohnloser, Stefan H; de Veer, Anne; Nordaby, Matias; Miede, Corinna; Kimura, Takeshi; Lip, Gregory Y H; Oldgren, Jonas; Cannon, Christopher P